DE69904206D1 - Verwendung von cetirizin zur vorbeugung von asthma eintritt - Google Patents
Verwendung von cetirizin zur vorbeugung von asthma eintrittInfo
- Publication number
- DE69904206D1 DE69904206D1 DE69904206T DE69904206T DE69904206D1 DE 69904206 D1 DE69904206 D1 DE 69904206D1 DE 69904206 T DE69904206 T DE 69904206T DE 69904206 T DE69904206 T DE 69904206T DE 69904206 D1 DE69904206 D1 DE 69904206D1
- Authority
- DE
- Germany
- Prior art keywords
- cetirizine
- entry
- prevent asthma
- asthma
- prevent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9692998P | 1998-08-18 | 1998-08-18 | |
US9745598P | 1998-08-21 | 1998-08-21 | |
PCT/EP1999/005969 WO2000010544A2 (en) | 1998-08-18 | 1999-08-14 | A method for preventing the onset of asthma |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69904206D1 true DE69904206D1 (de) | 2003-01-09 |
DE69904206T2 DE69904206T2 (de) | 2003-07-17 |
Family
ID=26792214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69904206T Expired - Lifetime DE69904206T2 (de) | 1998-08-18 | 1999-08-14 | Verwendung von cetirizin zur vorbeugung von asthma eintritt |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1109557B1 (de) |
JP (1) | JP3878416B2 (de) |
AR (1) | AR020167A1 (de) |
AT (1) | ATE228366T1 (de) |
AU (1) | AU749169B2 (de) |
CA (1) | CA2340920C (de) |
DE (1) | DE69904206T2 (de) |
ES (1) | ES2188232T3 (de) |
HN (1) | HN1999000140A (de) |
MA (1) | MA26676A1 (de) |
MY (1) | MY124089A (de) |
PA (1) | PA8480401A1 (de) |
SA (1) | SA99200492B1 (de) |
TN (1) | TNSN99158A1 (de) |
TW (1) | TW581675B (de) |
WO (1) | WO2000010544A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002221854A1 (en) * | 2000-12-15 | 2002-06-24 | U C B, S.A. | Use of cetirizine or efletirizine for preventing urticaria |
WO2005077371A1 (en) * | 2004-02-12 | 2005-08-25 | Ucb Farchim Sa | Use of levocetirizine for the preparation of a drug |
US8263581B2 (en) | 2009-07-03 | 2012-09-11 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
US8513259B2 (en) | 2009-07-03 | 2013-08-20 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
-
1999
- 1999-07-23 TW TW088112517A patent/TW581675B/zh not_active IP Right Cessation
- 1999-08-12 AR ARP990104039A patent/AR020167A1/es not_active Application Discontinuation
- 1999-08-13 MA MA25733A patent/MA26676A1/fr unknown
- 1999-08-13 HN HN1999000140A patent/HN1999000140A/es unknown
- 1999-08-13 MY MYPI99003475A patent/MY124089A/en unknown
- 1999-08-14 CA CA002340920A patent/CA2340920C/en not_active Expired - Fee Related
- 1999-08-14 JP JP2000565866A patent/JP3878416B2/ja not_active Expired - Fee Related
- 1999-08-14 DE DE69904206T patent/DE69904206T2/de not_active Expired - Lifetime
- 1999-08-14 EP EP99944395A patent/EP1109557B1/de not_active Expired - Lifetime
- 1999-08-14 ES ES99944395T patent/ES2188232T3/es not_active Expired - Lifetime
- 1999-08-14 AU AU57346/99A patent/AU749169B2/en not_active Ceased
- 1999-08-14 AT AT99944395T patent/ATE228366T1/de not_active IP Right Cessation
- 1999-08-14 WO PCT/EP1999/005969 patent/WO2000010544A2/en active IP Right Grant
- 1999-08-16 TN TNTNSN99158A patent/TNSN99158A1/fr unknown
- 1999-08-17 PA PA19998480401A patent/PA8480401A1/es unknown
- 1999-08-18 SA SA99200492A patent/SA99200492B1/ar unknown
Also Published As
Publication number | Publication date |
---|---|
CA2340920A1 (en) | 2000-03-02 |
EP1109557B1 (de) | 2002-11-27 |
PA8480401A1 (es) | 2000-09-29 |
TW581675B (en) | 2004-04-01 |
MA26676A1 (fr) | 2004-12-20 |
TNSN99158A1 (ar) | 2005-11-10 |
WO2000010544A3 (en) | 2000-05-18 |
AU5734699A (en) | 2000-03-14 |
MY124089A (en) | 2006-06-30 |
HN1999000140A (es) | 2001-07-31 |
AR020167A1 (es) | 2002-04-10 |
CA2340920C (en) | 2007-10-16 |
WO2000010544A2 (en) | 2000-03-02 |
DE69904206T2 (de) | 2003-07-17 |
ATE228366T1 (de) | 2002-12-15 |
ES2188232T3 (es) | 2003-06-16 |
JP3878416B2 (ja) | 2007-02-07 |
EP1109557A2 (de) | 2001-06-27 |
AU749169B2 (en) | 2002-06-20 |
JP2002523362A (ja) | 2002-07-30 |
SA99200492B1 (ar) | 2006-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69903655D1 (de) | Verwendung von menthyl-2-pyrrolidon-5-carboxylat zur insektenabwehr | |
DE60037213D1 (de) | Verwendung von Reinigungsgas | |
DE69833134D1 (de) | Verwendung aliphatischer amine zur verminderung von oxalat | |
DE59810802D1 (de) | Verwendung von anorganisch-organischen hybridprepolymeren | |
DE59905858D1 (de) | Verwendung von pit-emulsionen | |
DE69928195D1 (de) | Komplettierung von Untrerdruck-Bohrlöchern | |
DE69927128D1 (de) | Verwendung von topisch applizierbaren Gerinnungsmaterial | |
ID27092A (id) | Pembuatan ftalat anhidrida | |
DE50012379D1 (de) | Verwendung von nanoskaligen antischuppenwirkstoffen | |
DE59807740D1 (de) | Verwendung von aerogelen zur körper- und/oder trittschalldämmung | |
DE50212455D1 (de) | Verwendung von Dimerdiolen | |
DE59902868D1 (de) | Verwendung von ectoin oder ectoin-derivaten in formulierungen | |
ATE301703T1 (de) | Verwendung von zusammensetzungen zur textilpflege | |
DE69936514D1 (de) | Heliomycin-kodierendes gen und seine verwendung | |
DE69934305D1 (de) | Verwendung von dexmedetomidine zur sedierung auf der intensivstation | |
DE69531048D1 (de) | Verwendung von steroidsulphatase-hemmern | |
DE69928437D1 (de) | Verwendung von paraoxanase-1 (pon-1) zur reduzierung der atheroma-bildung und der hypercholesterolemie | |
DE69922558D1 (de) | Herstellung von Aluminiumoxid | |
DE69904206D1 (de) | Verwendung von cetirizin zur vorbeugung von asthma eintritt | |
DE69908951D1 (de) | Kristallformen von osanetant | |
DE59811806D1 (de) | Verwendung von ausgewählten phytostenolestern zur herstellung von hypocholesterinämischen mitteln | |
ATE303153T1 (de) | Ibandroinsäure zur förderung der osseointegration der endoprothesen | |
DE69904567D1 (de) | Lipidmischung sowie ihre verwendung | |
DE69711223D1 (de) | Verwendung von cordia dichotoma extrakten | |
DE50006852D1 (de) | Verwendung von nanoskaligen deodorantien |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: UCB FARCHIM S.A., BULLE, CH |